The hemostats market focuses on medical products used to control bleeding during surgeries or after injuries. These products help promote clotting and are essential in various procedures, including cardiac, orthopedic, and general surgeries. Hemostats come in different forms, such as sponges, powders, gels, and patches, and are widely used in hospitals and surgical centers. The market is growing due to the increasing number of surgeries, rising trauma cases, and advancements in hemostatic technologies. North America currently leads the market, while Asia-Pacific is experiencing rapid growth due to expanding healthcare infrastructure and rising surgical needs.
According to Fortune Business Insights, the global hemostats market was valued at USD 4.75 billion in 2023 and is projected to grow from USD 5.09 billion in 2024 to USD 9.33 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.9% during the forecast period (2024–2032). In 2023, North America dominated the market with a 35.16% share.
In November 2023, Ethicon (a subsidiary of Johnson & Johnson Medical Devices Companies) secured CE Mark approval for its ETHIZIA Hemostatic Sealing Patch. The product is slated for launch in the EMEA region in Q1 2024.